960 related articles for article (PubMed ID: 15471148)
1. [Hypertension, dyslipidemia and cardiovascular risk in chronic renal disease].
Ravera M; Paoletti E
Ital Heart J Suppl; 2004 Jun; 5(6):436-44. PubMed ID: 15471148
[TBL] [Abstract][Full Text] [Related]
2. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
[TBL] [Abstract][Full Text] [Related]
3. [Glomerular filtration rate and cardiovascular risk: prognostic and therapeutic implications].
Ratto E; Leoncini G; Viazzi F; Pontremoli R
G Ital Nefrol; 2008; 25(1):21-31. PubMed ID: 18264915
[TBL] [Abstract][Full Text] [Related]
4. [Diminished glomerular filtration rate as a marker of chronic kidney disease in hypertensive patients].
Grabysa R; Cholewa M
Pol Merkur Lekarski; 2008 Jun; 24(144):487-91. PubMed ID: 18702327
[TBL] [Abstract][Full Text] [Related]
5. Treatment of hypertension in chronic kidney disease.
Toto RD
Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
[TBL] [Abstract][Full Text] [Related]
6. K/DOQI gets to the heart of managing dyslipidemias in patients with CKD.
Benner D
Nephrol Nurs J; 2005; 32(3):337-8. PubMed ID: 16035475
[TBL] [Abstract][Full Text] [Related]
7. [Cardiovascular risk in hemodialysis in Spain: prevalence, management and target results (MAR study)].
Portolés J; López-Gómez JM; Aljama P
Nefrologia; 2005; 25(3):297-306. PubMed ID: 16053011
[TBL] [Abstract][Full Text] [Related]
8. [Guidelines of the Spanish Society of Nephrology: the kidney and cardiovascular disease. Short version].
Marín R; Goicoechea MA; Gorostidi M; Cases A; Díez J; Escolar G; Fernández-Vega F; Palomar R; Rodrigo E; Martínez I; Segura J;
Nefrologia; 2006; 26(1):31-44. PubMed ID: 16649424
[No Abstract] [Full Text] [Related]
9. Chronic kidney disease and cardiovascular disease--using the ANNA Standards and Practice Guidelines to improve care. Part 1: the epidemiology of chronic kidney disease: the risk factors and complications that contribute to cardiovascular disease.
McCarley PB; Burrows-Hudson S
Nephrol Nurs J; 2006; 33(6):666-74; quiz 675-6. PubMed ID: 17219728
[TBL] [Abstract][Full Text] [Related]
10. Plasma lipoprotein abnormalities in hemodialysis patients--clinical implications and therapeutic guidelines.
Shoji T; Nishizawa Y
Ther Apher Dial; 2006 Aug; 10(4):305-15. PubMed ID: 16911182
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion.
Brantsma AH; Bakker SJ; Hillege HL; de Zeeuw D; de Jong PE; Gansevoort RT;
Nephrol Dial Transplant; 2008 Dec; 23(12):3851-8. PubMed ID: 18641082
[TBL] [Abstract][Full Text] [Related]
12. Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease.
Wang MC; Tsai WC; Chen JY; Huang JJ
Am J Kidney Dis; 2005 Mar; 45(3):494-501. PubMed ID: 15754271
[TBL] [Abstract][Full Text] [Related]
13. The unique character of cardiovascular disease in chronic kidney disease and its implications for treatment with lipid-lowering drugs.
Nogueira J; Weir M
Clin J Am Soc Nephrol; 2007 Jul; 2(4):766-85. PubMed ID: 17699494
[TBL] [Abstract][Full Text] [Related]
14. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
Ravera M; Noberasco G; Re M; Filippi A; Gallina AM; Weiss U; Cannavò R; Ravera G; Cricelli C; Deferrari G
Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656
[TBL] [Abstract][Full Text] [Related]
15. Cardiorenal interaction: appropriate treatment of cardiovascular risk factors to improve outcomes in chronic kidney disease.
McCullough PA; Verrill TA
Postgrad Med; 2010 Mar; 122(2):25-34. PubMed ID: 20203453
[TBL] [Abstract][Full Text] [Related]
16. Chronic kidney disease and global cardiovascular risk in essential hypertension.
Segura J; Campo C; Ruilope LM
Minerva Med; 2004 Oct; 95(5):375-83. PubMed ID: 15467513
[TBL] [Abstract][Full Text] [Related]
17. Management of chronic kidney disease after renal transplantation: is it different from nontransplant patients?
Jiménez Alvaro S; Marcén R; Teruel JL; Fernández Rodríguez A; Pascual J; Galeano C; Villacorta J; Burgos FJ; Ortuño J
Transplant Proc; 2009; 41(6):2409-11. PubMed ID: 19715935
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular disease risk factors in chronic kidney disease: overall burden and rates of treatment and control.
Parikh NI; Hwang SJ; Larson MG; Meigs JB; Levy D; Fox CS
Arch Intern Med; 2006 Sep; 166(17):1884-91. PubMed ID: 17000946
[TBL] [Abstract][Full Text] [Related]
19. An assessment of cholesterol goal attainment in patients with chronic kidney disease.
Stadler SL; Bhardwaja B; Olson KL; Powers JD; Lanese D
J Clin Lipidol; 2010; 4(4):298-304. PubMed ID: 21122663
[TBL] [Abstract][Full Text] [Related]
20. Left ventricular hypertrophy versus chronic kidney disease as predictors of cardiovascular events in hypertension: a Greek 6-year-follow-up study.
Tsioufis C; Vezali E; Tsiachris D; Dimitriadis K; Taxiarchou E; Chatzis D; Thomopoulos C; Syrseloudis D; Stefanadi E; Mihas C; Katsi V; Papademetriou V; Stefanadis C
J Hypertens; 2009 Apr; 27(4):744-52. PubMed ID: 19516174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
